Cargando…
Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation
This study aimed to determine the effects of lidocaine on cell proliferation and cisplatin resistance in A431 human cutaneous squamous cell carcinoma (cSCC) cells and elucidate the underlying mechanism. Cell proliferation, colony numbers, and cisplatin resistance were determined in A431 or cisplatin...
Autores principales: | Liu, Tao, Jiang, Fei, Yu, Li-Yuan, Wu, You-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974189/ https://www.ncbi.nlm.nih.gov/pubmed/35212616 http://dx.doi.org/10.1080/21655979.2022.2031419 |
Ejemplares similares
-
miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1
por: Song, Xiang, et al.
Publicado: (2019) -
miR-34a/SIRT6 in squamous differentiation and cancer
por: Dotto, G Paolo, et al.
Publicado: (2014) -
MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP
por: Pang, Yingxin, et al.
Publicado: (2014) -
miR-30a suppresses lung cancer progression by targeting SIRT1
por: Guan, Yaowu, et al.
Publicado: (2017) -
MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020)